Immuno-senescence is another plausible culprit: the decrease in the rate of antibodies against Stx1 and Stx2 observed after the fifth decade in humans could translate into delayed toxin clearance, hence the increased mortality of STEC-HUS in elderly patients [113]. The gene discussed is STX2; the disease is hemolytic-uremic syndrome.